Jan 12, 2021 / 01:20PM GMT
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Great. Good morning, and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, at the JPMorgan Healthcare Conference, it's my pleasure to introduce Siggi Olafsson, CEO of Hikma, for this presentation. And today, we're going to have a 20-minute presentation from Siggi, and then we're going to have 20 minutes for your questions. And you can immediately start registering your questions. (Operator Instructions). If you've any problems with that, you can also e-mail me.
And with that said, I'd like to welcome Siggi to the conference. Siggi, over to you for the presentation.
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director
Thank you, James. Good morning, and good afternoon, everyone. Pleasure to be with you, even though virtually like we are doing today. If we just go straight into the slide deck, if we go to Slide #3. If we start there, it's been almost 3 years since I joined Hikma. And over the time, these 3
Hikma Pharmaceuticals PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers